240 related articles for article (PubMed ID: 25995385)
1. Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor.
Dorr C; Janik C; Weg M; Been RA; Bader J; Kang R; Ng B; Foran L; Landman SR; O'Sullivan MG; Steinbach M; Sarver AL; Silverstein KA; Largaespada DA; Starr TK
Mol Cancer Res; 2015 Aug; 13(8):1238-47. PubMed ID: 25995385
[TBL] [Abstract][Full Text] [Related]
2. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
Janik CL; Starr TK
J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
[TBL] [Abstract][Full Text] [Related]
3. Sleeping Beauty Transposon Mutagenesis Identifies Genes Driving the Initiation and Metastasis of Uterine Leiomyosarcoma.
Kodama M; Shimura H; Tien JC; Newberg JY; Kodama T; Wei Z; Rangel R; Yoshihara K; Kuruma A; Nakae A; Hashimoto K; Sawada K; Kimura T; Jenkins NA; Copeland NG
Cancer Res; 2021 Nov; 81(21):5413-5424. PubMed ID: 34475109
[TBL] [Abstract][Full Text] [Related]
4. A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.
de la Rosa J; Weber J; Friedrich MJ; Li Y; Rad L; Ponstingl H; Liang Q; de Quirós SB; Noorani I; Metzakopian E; Strong A; Li MA; Astudillo A; Fernández-García MT; Fernández-García MS; Hoffman GJ; Fuente R; Vassiliou GS; Rad R; López-Otín C; Bradley A; Cadiñanos J
Nat Genet; 2017 May; 49(5):730-741. PubMed ID: 28319090
[TBL] [Abstract][Full Text] [Related]
5. Sleeping Beauty transposon mutagenesis identifies genes that cooperate with mutant Smad4 in gastric cancer development.
Takeda H; Rust AG; Ward JM; Yew CC; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):E2057-65. PubMed ID: 27006499
[TBL] [Abstract][Full Text] [Related]
6. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression.
Rangel R; Lee SC; Hon-Kim Ban K; Guzman-Rojas L; Mann MB; Newberg JY; Kodama T; McNoe LA; Selvanesan L; Ward JM; Rust AG; Chin KY; Black MA; Jenkins NA; Copeland NG
Proc Natl Acad Sci U S A; 2016 Nov; 113(48):E7749-E7758. PubMed ID: 27849608
[TBL] [Abstract][Full Text] [Related]
7. Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
Morris SM; Davison J; Carter KT; O'Leary RM; Trobridge P; Knoblaugh SE; Myeroff LL; Markowitz SD; Brett BT; Scheetz TE; Dupuy AJ; Starr TK; Grady WM
Int J Cancer; 2017 Feb; 140(4):853-863. PubMed ID: 27790711
[TBL] [Abstract][Full Text] [Related]
8. Transposon mutagenesis identifies chromatin modifiers cooperating with
Montero-Conde C; Leandro-Garcia LJ; Chen X; Oler G; Ruiz-Llorente S; Ryder M; Landa I; Sanchez-Vega F; La K; Ghossein RA; Bajorin DF; Knauf JA; Riordan JD; Dupuy AJ; Fagin JA
Proc Natl Acad Sci U S A; 2017 Jun; 114(25):E4951-E4960. PubMed ID: 28584132
[TBL] [Abstract][Full Text] [Related]
9. Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression.
Zhang C; Liu J; Huang G; Zhao Y; Yue X; Wu H; Li J; Zhu J; Shen Z; Haffty BG; Hu W; Feng Z
Genes Dev; 2016 Sep; 30(17):1956-70. PubMed ID: 27664236
[TBL] [Abstract][Full Text] [Related]
10. Transposon mutagenesis identifies genetic drivers of Braf(V600E) melanoma.
Mann MB; Black MA; Jones DJ; Ward JM; Yew CC; Newberg JY; Dupuy AJ; Rust AG; Bosenberg MW; McMahon M; Print CG; Copeland NG; Jenkins NA
Nat Genet; 2015 May; 47(5):486-95. PubMed ID: 25848750
[TBL] [Abstract][Full Text] [Related]
11.
Rahrmann EP; Wolf NK; Otto GM; Heltemes-Harris L; Ramsey LB; Shu J; LaRue RS; Linden MA; Rathe SK; Starr TK; Farrar MA; Moriarity BS; Largaespada DA
Mol Cancer Res; 2019 Feb; 17(2):567-582. PubMed ID: 30355676
[TBL] [Abstract][Full Text] [Related]
12. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
[TBL] [Abstract][Full Text] [Related]
13. Impact of KEAP1/NFE2L2/CUL3 mutations on duration of response to EGFR tyrosine kinase inhibitors in EGFR mutated non-small cell lung cancer.
Hellyer JA; Stehr H; Das M; Padda SK; Ramchandran K; Neal JW; Diehn M; Wakelee HA
Lung Cancer; 2019 Aug; 134():42-45. PubMed ID: 31319993
[TBL] [Abstract][Full Text] [Related]
14. PTEN mutations and relationship to EGFR, ERBB2, KRAS, and TP53 mutations in non-small cell lung cancers.
Jin G; Kim MJ; Jeon HS; Choi JE; Kim DS; Lee EB; Cha SI; Yoon GS; Kim CH; Jung TH; Park JY
Lung Cancer; 2010 Sep; 69(3):279-83. PubMed ID: 20018398
[TBL] [Abstract][Full Text] [Related]
15. An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling.
Xu H; Sun H; Zhang H; Liu J; Fan F; Li Y; Ning X; Sun Y; Dai S; Liu B; Gao M; Fu S; Zhou C
PLoS One; 2015; 10(5):e0124033. PubMed ID: 25962159
[TBL] [Abstract][Full Text] [Related]
16. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
[TBL] [Abstract][Full Text] [Related]
17. E3 ligase MKRN3 is a tumor suppressor regulating PABPC1 ubiquitination in non-small cell lung cancer.
Li K; Zheng X; Tang H; Zang YS; Zeng C; Liu X; Shen Y; Pang Y; Wang S; Xie F; Lu X; Luo Y; Li Z; Bi W; Jia X; Huang T; Wei R; Huang K; Chen Z; Zhu Q; He Y; Zhang M; Gu Z; Xiao Y; Zhang X; Fletcher JA; Wang Y
J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34143182
[TBL] [Abstract][Full Text] [Related]
18. Radiation/paclitaxel treatment of p53-abnormal non-small cell lung cancer xenograft tumor and associated mechanism.
Li G; Zhao J; Peng X; Liang J; Deng X; Chen Y
Cancer Biother Radiopharm; 2012 May; 27(4):227-33. PubMed ID: 22489661
[TBL] [Abstract][Full Text] [Related]
19. Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
Ota K; Azuma K; Kawahara A; Hattori S; Iwama E; Tanizaki J; Harada T; Matsumoto K; Takayama K; Takamori S; Kage M; Hoshino T; Nakanishi Y; Okamoto I
Clin Cancer Res; 2015 Sep; 21(17):4014-21. PubMed ID: 26019170
[TBL] [Abstract][Full Text] [Related]
20. Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimens.
Bar J; Damianovich M; Hout Siloni G; Dar E; Cohen Y; Perelman M; Ben Nun A; Simansky D; Yellin A; Urban D; Onn A
Clin Lung Cancer; 2014 Mar; 15(2):159-65. PubMed ID: 24370118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
